Shukra Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.61",
    "chg": 1.83,
    "chgp": "4.84%",
    "dir": 1,
    "prev_price": "37.78",
    "mcapval": "1,728.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE551C01044",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2.53 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shukra Pharmaceuticals Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-technical-momentum-shifts-amid-strong-long-term-returns-3745419",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShukraPharmaceu_technicaldot_3745419.png",
        "date": "2025-12-04 08:06:26",
        "description": "Shukra Pharmaceuticals has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. While weekly and monthly MACD readings maintain a bullish stance, other metrics such as the monthly RSI and KST suggest caution, underscoring a period of consolidation and mild volatility for the stock."
      },
      {
        "title": "Shukra Pharmaceuticals Shows Bullish Momentum Amid Technical Parameter Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-technical-momentum-shifts-signal-bullish-outlook-3742793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShukraPharmaceu_technicaldot_3742793.png",
        "date": "2025-12-03 08:04:25",
        "description": "Shukra Pharmaceuticals has exhibited a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. Recent changes in the company’s evaluation metrics have coincided with positive signals from moving averages, MACD, and Bollinger Bands, suggesting a strengthening trend in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shukra Pharmaceuticals: Technical Momentum Shift Signals Mixed Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-technical-momentum-shifts-amid-mixed-indicator-signals-3740079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShukraPharmaceu_technicaldot_3740079.png",
        "date": "2025-12-02 08:05:51",
        "description": "Shukra Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment amid its recent price movements. While weekly and monthly MACD indicators maintain a bullish stance, other technical parameters such as the monthly RSI and KST suggest caution, highlighting a complex interplay of forces influencing the stock’s trajectory."
      },
      {
        "title": "Shukra Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharma-upgraded-from-sell-to-hold-by-marketsmojo-on-17-jul-2025-3736955",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShukraPharma_mojoScore_3736955.png",
        "date": "2025-11-29 17:52:00",
        "description": "Shukra Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of strong long-term returns contrasted by recent quarterly challenges and a valuation that remains elevated relative to peers."
      },
      {
        "title": "Why is Shukra Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shukra-pharma-fallingrising-3734252",
        "imagepath": "",
        "date": "2025-11-28 00:24:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Shukra Pharmaceuticals opened the day with a gap down of 4.47%, signalling immediate selling pressure from the outset of trading. The stock’s intraday low touched ₹37.01, reflecting sustained weakness throughout the session. This decline is part of a two-day losing streak, during which the stock has fallen by nearly 6%, underperforming its sector by 2.93% on the day. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, suggesting that sellers dominated the market sentiment.</p>\n<p>Despite this short-term weakness, it is important to note that Shukra Pharma’s price remains well above its 50-day, 100-day, and 200-day moving averages, indicating that the longer-term trend remains positive. H..."
      },
      {
        "title": "Shukra Pharmaceuticals Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-technical-momentum-shifts-signal-bullish-outlook-amid-volatility-3732394",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShukraPharmaceu_technicaldot_3732394.png",
        "date": "2025-11-27 08:03:24",
        "description": "Shukra Pharmaceuticals, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a nuanced shift in its technical momentum. Recent market data reveals a blend of bullish and bearish indicators across multiple timeframes, reflecting a complex market assessment for the stock as it navigates price fluctuations and evolving investor sentiment."
      },
      {
        "title": "Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Lower Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-faces-intense-selling-pressure-amid-lower-circuit-lockdown-3731115",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShukraPharmaceu_only_sellers_3731115.png",
        "date": "2025-11-26 10:10:30",
        "description": "Shukra Pharmaceuticals has encountered significant selling pressure today, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The pharmaceutical company’s shares have recorded consecutive losses, reflecting distress selling signals that have unsettled investors and market watchers alike."
      },
      {
        "title": "Shukra Pharmaceuticals Exhibits Mixed Technical Signals Amid Strong Long-Term Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-technical-momentum-shifts-amid-strong-long-term-returns-3730184",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShukraPharmaceu_technicaldot_3730184.png",
        "date": "2025-11-26 08:03:46",
        "description": "Shukra Pharmaceuticals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. While the stock’s recent price movements show a mild bullish trend, certain momentum oscillators suggest caution, underscoring the importance of a balanced analysis for investors navigating this evolving landscape."
      },
      {
        "title": "Shukra Pharmaceuticals Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-hits-upper-circuit-amid-unprecedented-buying-frenzy-3728098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShukraPharmaceu_only_buyers_3728098.png",
        "date": "2025-11-25 09:40:35",
        "description": "Shukra Pharmaceuticals has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit limit and an exclusive queue of buy orders dominating the market. This rare scenario signals robust investor enthusiasm and the potential for a sustained multi-day circuit, setting the stage for notable market attention in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 583,
    "sid": "505931",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Update on board meeting",
      "datetime": "30-Jan-2026",
      "details": "The Board Meeting to be held on 07/02/2026 has been revised to 04/02/2026 The Board Meeting to be held on 07/02/2026 has been revised to 04/02/2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Unaudited Financial Result For The Third Quarter Ended On 31 December 2025 Along With The Auditors Limited Review Report.",
      "datetime": "30-Jan-2026",
      "details": "Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter alia to consider and approve Unaudited financial result for the Third Quarter ended on 31 December 2025 along with the Auditors Limited Review Report.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Today",
      "datetime": "28-Jan-2026",
      "details": "Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Shukra Pharmaceuticals Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-04 08:06:26

Shukra Pharmaceuticals has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. While weekly and monthly MACD readings maintain a bullish stance, other metrics such as the monthly RSI and KST suggest caution, underscoring a period of consolidation and mild volatility for the stock.

Shukra Pharmaceuticals Shows Bullish Momentum Amid Technical Parameter Revision

2025-12-03 08:04:25

Shukra Pharmaceuticals has exhibited a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. Recent changes in the company’s evaluation metrics have coincided with positive signals from moving averages, MACD, and Bollinger Bands, suggesting a strengthening trend in the Pharmaceuticals & Biotechnology sector.

Shukra Pharmaceuticals: Technical Momentum Shift Signals Mixed Market Sentiment

2025-12-02 08:05:51

Shukra Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment amid its recent price movements. While weekly and monthly MACD indicators maintain a bullish stance, other technical parameters such as the monthly RSI and KST suggest caution, highlighting a complex interplay of forces influencing the stock’s trajectory.

Shukra Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-11-29 17:52:00

Shukra Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of strong long-term returns contrasted by recent quarterly challenges and a valuation that remains elevated relative to peers.

Why is Shukra Pharma. falling/rising?

2025-11-28 00:24:22

Recent Price Movement and Market Context Shukra Pharmaceuticals opened the day with a gap down of 4.47%, signalling immediate selling pressure from the outset of trading. The stock’s intraday low touched ₹37.01, reflecting sustained weakness throughout the session. This decline is part of a two-day losing streak, during which the stock has fallen by nearly 6%, underperforming its sector by 2.93% on the day. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, suggesting that sellers dominated the market sentiment. Despite this short-term weakness, it is important to note that Shukra Pharma’s price remains well above its 50-day, 100-day, and 200-day moving averages, indicating that the longer-term trend remains positive. H...

Shukra Pharmaceuticals Shows Mixed Technical Signals Amid Price Momentum Shift

2025-11-27 08:03:24

Shukra Pharmaceuticals, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a nuanced shift in its technical momentum. Recent market data reveals a blend of bullish and bearish indicators across multiple timeframes, reflecting a complex market assessment for the stock as it navigates price fluctuations and evolving investor sentiment.

Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Lower Circuit

2025-11-26 10:10:30

Shukra Pharmaceuticals has encountered significant selling pressure today, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The pharmaceutical company’s shares have recorded consecutive losses, reflecting distress selling signals that have unsettled investors and market watchers alike.

Shukra Pharmaceuticals Exhibits Mixed Technical Signals Amid Strong Long-Term Returns

2025-11-26 08:03:46

Shukra Pharmaceuticals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. While the stock’s recent price movements show a mild bullish trend, certain momentum oscillators suggest caution, underscoring the importance of a balanced analysis for investors navigating this evolving landscape.

Shukra Pharmaceuticals Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit

2025-11-25 09:40:35

Shukra Pharmaceuticals has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit limit and an exclusive queue of buy orders dominating the market. This rare scenario signals robust investor enthusiasm and the potential for a sustained multi-day circuit, setting the stage for notable market attention in the Pharmaceuticals & Biotechnology sector.

View All News